A retrospective trial evaluating the efficacy and toxicity of bevacizumab combined with cisplatin in late-stage malignant carcinoma patients with malignant pleural effusion and ascites

Trial Profile

A retrospective trial evaluating the efficacy and toxicity of bevacizumab combined with cisplatin in late-stage malignant carcinoma patients with malignant pleural effusion and ascites

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Bevacizumab; Cisplatin
  • Indications Ascites; Cancer; Malignant pleural effusion
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 28 Mar 2016 New trial record
    • 01 Mar 2016 Results (n=43) published in the Anticancer Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top